INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
KR
Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
5,238 sh
Apr 1, 2026Apr 3, 2026
Page 1026 of 1742
← PrevNext →
traded Apr 1, 2026
+2d
SEC Form 4

Evidence

5
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
775.8K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

4
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
882 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
4,464 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
22.1K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
782 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
30.6K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
AJ
Allison JonathanChief Administrative Officer
ROOTRoot, Inc.
Option exercise · 10b5-1 plan
M—
6,442 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

3
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
73.0K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

2
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Tax withholding
F$27K
1,297 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

2
AJ
Allison JonathanChief Administrative Officer
ROOTRoot, Inc.
Tax withholding · 10b5-1 plan
F$124K
2,874 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

2
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Tax withholding · 10b5-1 plan
F$69K
11.6K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MA
Majalya Sidney A.SVP, CLO and Secretary
TNETTRINET GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$29K
775 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
952 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$211K
1,048 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
552 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Option exercise · 10b5-1 plan
M—
2,409 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,409 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
4,468 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
4,464 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,409 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Tax withholding · 10b5-1 plan
F$4,295
70 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
207 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
611 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
22.1K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
782 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
207 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
611 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Option exercise · 10b5-1 plan
M—
2,409 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
552 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
39.7K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

0
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
882 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
4,468 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence